Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
9.37
-0.17 (-1.83%)
At close: Jun 5, 2025, 4:00 PM
9.34
-0.03 (-0.27%)
After-hours: Jun 5, 2025, 4:00 PM EDT
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $242.41 million as of June 5, 2025. Its market cap has decreased by -48.46% in one year.
Market Cap
242.41M
Enterprise Value
76.05M
1-Year Change
-48.46%
Ranking
Category
Stock Price
$9.37
Market Cap Chart
Since June 22, 2016, Cartesian Therapeutics's market cap has increased from $236.80M to $242.41M, an increase of 2.37%. That is a compound annual growth rate of 0.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2025 | 247.60M | -45.61% |
| Dec 31, 2024 | 455.20M | 325.42% |
| Dec 29, 2023 | 107.00M | -38.11% |
| Dec 30, 2022 | 172.90M | -54.54% |
| Dec 31, 2021 | 380.30M | 16.19% |
| Dec 31, 2020 | 327.30M | 185.35% |
| Dec 31, 2019 | 114.70M | 92.13% |
| Dec 31, 2018 | 59.70M | -72.75% |
| Dec 29, 2017 | 219.10M | -29.78% |
| Dec 30, 2016 | 312.00M | 31.76% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.52B |
| Johnson & Johnson | 368.66B |
| AbbVie | 330.92B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 272.49B |
| Abbott Laboratories | 231.33B |
| Novartis AG | 229.87B |
| AstraZeneca | 226.47B |